-+ 0.00%
-+ 0.00%
-+ 0.00%

Can-Fite submits Phase 2 Lowe syndrome trial protocol for Piclidenoson to Italy hospital

PUBT·08/03/2026 11:02:20
Listen to the news
Can-Fite submits Phase 2 Lowe syndrome trial protocol for Piclidenoson to Italy hospital
  • Can-Fite submitted a Phase 2 trial protocol for Piclidenoson in Lowe syndrome to Bambino Gesù Children’s Hospital in Rome for review.
  • Open-label, single-center study targets 5 adults over six months, aiming to support regulatory discussions and a potential registration pathway on positive results.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Can Fite Biofpharma Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608030700PRIMZONEFULLFEED9802377) on August 03, 2026, and is solely responsible for the information contained therein.